Open an Account
search icon
3
NOTIFICATIONS
Best Algo trading app in India
Bigul

Earum Pharmaceuticals Ltd - 542724 - Intimation Of Record Date For Issue Of Equity Shares On Rights ('Rights Issue')

 Pursuant to Regulation 42 of the SEBI (Listing Obligations and Disclosure Requirements), 2015, the Company has fixed Monday, 10th April, 2023 as the Record Date, for the purpose of ascertaining the eligibility of shareholders entitled for issuance of 4 (Four) Fully paid-up Equity shares of the Company having face value of Rs. 2/- (Rupees Two Only) each for every 1 (One) Equity share held by the eligible existing equity shareholder in the Company on Rights basis ('Rights Issue').
31-03-2023
Bigul

Earum Pharmaceuticals Ltd - 542724 - Announcement under Regulation 30 (LODR)-Newspaper Publication

 Pursuant to Regulation 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the Company has given Newspaper Advertisement on 13th February, 2023 of Unaudited Financial Result for the quarter and Nine Month ended on 31st December, 2022 in 1. English Newspaper - The Indian Express Newspaper and 2. Regional Language Newspaper (Gujarati) - Financial Express Newspaper
13-02-2023
Bigul

Earum Pharmaceuticals Ltd - 542724 - Submission Of Unaudited Financial Results For The Quarter And Nine Months Ended On 31St December, 2022 Along With Limited Review Report

 In reference to captioned subject and pursuant to Regulation 33(3) (d) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are hereby submitting the Unaudited Financial Results for the quarter and Nine Months ended on 31st December, 2022 along with Limited Review Report
10-02-2023
Bigul

Earum Pharmaceuticals Ltd - 542724 - Board Meeting Outcome for Outcome Of Board Meeting Held Today I.E. On 10Th February, 2023

 Pursuant to second proviso to Regulation 30(6) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that the Board of Directors of the Company, in their meeting held today, i.e. on 10th February, 2023 at the Registered Office of the Company, which commenced at 4:00 P.M. and concluded at 4:30 P.M. has Considered and approved the Unaudited Financial Results along with Limited Review Report for the Quarter and Nine Months ended on 31st December, 2022
10-02-2023
Bigul

Earum Pharmaceuticals Ltd - 542724 - Scrutinizer Report For Extraordinary General Meeting Of 2022-23

 Pursuant to Section 108 and 109 of the Company Act, 2013 read with Rule 20 & 21 of the Companies (Management and Administration) Rules, 2014, we are submitting herewith the Scrutinizer Report of the Extra Ordinary General Meeting of the Company be held Saturday, 4th February, 2023 at 12:00 P.M. through Video Conferencing (VC) / Other Audio Video Means (OAVM).
06-02-2023
Bigul

Earum Pharmaceuticals Ltd - 542724 - Outcome Of Extra Ordinary General Meeting Held On 4Th February, 2023 In Terms Of The Regulation 30 Of The SEBI (LODR) Regulations, 2015.

 Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that the members of the Company at their Extra Ordinary General Meeting of the Company held today i.e. on 4th February, 2023 through Video Conferencing (VC) / Other Audio Video Means (OAVM) which was commenced on 12:00 P.M. and concluded on 12:07 P.M., have discussed and considered the businesses mentioned in the notice of Extra Ordinary General Meeting.
04-02-2023
Bigul

Earum Pharmaceuticals Ltd - 542724 - Board Meeting Intimation for Intimation Of Board Meeting To Be Held On 10Th February, 2023

 Earum Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/02/2023 ,inter alia, to consider and approve This is to inform you that a meeting of the Board of Directors of the Company will be held on Friday, 10th February, 2023 at 4:00 P.M. at the registered office of the Company situated at Survey A-1106, Empire Business Hub Near AUDA Water Tank, Science City Road, Sola Ahmedabad - 380 060 inter alia, to consider and approve the Unaudited Financial Results of the Company for the Quarter and Nine Months ended on 31st December, 2022 along with Limited Review Report.
31-01-2023
Bigul

Earum Pharmaceuticals Ltd - 542724 - Board Meeting Outcome for Outcome Of Board Meeting Held Today I.E. 24Th January, 2023

 Pursuant to second proviso to Regulation 30(6) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that the Board of Directors in their meeting held today i.e. 24th January, 2023 at the Registered Office of the Company which commenced at 4:00 P.M. and concluded at 5:00 P.M. inter-alia has considered and approved as par attachment.
24-01-2023
Bigul

Earum Pharmaceuticals Ltd - 542724 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

 With reference to the captioned subject, we hereby submit the confirmation Certificate received from M/s. Bigshare Services Private Limited, Registrar and Share Transfer Agent (RTA) as per Regulation 74(5) of the Securities and Exchange Board India (Depository and Participant) Regulations, 2018 for the Quarter and Nine Months ended on 31st December, 2022. Kindly take the same on your record and oblige us.
17-01-2023
Bigul

Earum Pharmaceuticals Ltd - 542724 - Announcement under Regulation 30 (LODR)-Newspaper Publication

 Pursuant to Regulation 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby enclose the copies of the public notice of the Extra Ordinary General Meeting of the Company to be held on Saturday, 4th February, 2023 at 12:00 P.M., published on 13th January, 2023 in: 1. English Newspaper - The Indian Express and 2. Regional Language Newspaper (Gujarati) - Financial Express
13-01-2023
Next Page
Close

Let's Open Free Demat Account